If you've been looking for high-yield stocks, Pfizer (PFE-1.40%) may have crossed your radar screen. As shares of the pharma ...

Oct 1 (Reuters) - Florida Attorney General James Uthmeier on Thursday filed a lawsuit against Pfizer and its CEO, Albert ...

Street Target (Mean): ~$29Next Earnings: November 3, 2026What Happened?Florida’s attorney general sued Pfizer (PFE:NYSE) and CEO Albert Bourla on Thursday, October 1, alleging the company misled ...

Pfizer's revenue over the past twelve months was 0.2% lower than a year earlier. When sales are flat, look at what management ...

Pfizer is making moves on the dermatology and wider immunology fronts, detailing two phase 3 wins for its oral Janus kinase inhibitor, Litfulo, and a promising phase 2 update for its investigationa | ...

Both face patent cliffs and pay generous dividends, but only one of them can tell you where its next wave of growth is coming ...

Florida Attorney General James Uthmeier filed a lawsuit Thursday against Pfizer Inc., alleging unfair and deceptive marketing of Pfizer’s COVID-19 vaccine. The suit, filed in state trial court in St.

The Trump administration has selected 10 companies, including AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), and GSK (GSK), for a new pilot program that tests a rebate model for drugs purchased under a ...

(NYSE: PFE) today presented detailed results from an ongoing Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate-t ...

Pfizer faces some major LoE headwinds, but the stock is cheap and offers a large dividend, offering a solid total return ...

LITFULO significantly improved facial and total body repigmentation at Week 52 compared to placebo, with continuous improvement starting at Week 24, supporting planned regulatory filings for a ...

VACCINE LAWSUIT  Florida's Attorney General is suing a major drugmaker, saying it misled patients about the benefits of its ...